A meta-analysis including 99 patients with AChR-MG and 57 patients with MuSK-MG treated with RTX demonstrated that minimal manifestations (MM) or better were achieved in 72% of MuSK-MG patients compared to 30% in AChR-MG patients (16). Here, MUSK is linked to myasthenia gravis.